MENU
LRMR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Larimar Therapeutics (LRMR) Earnings Date & Reports
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform... Show more
A.I. Advisor
published Earnings
LRMR is expected to report earnings to rise 27.71% to -39 cents per share on August 06
Q2'26
Est.
$-0.40
Q1'26
Beat
by $0.22
Q4'25
Missed
by $0.24
Q3'25
Missed
by $0.20
Q2'25
Beat
by $0.07
The last earnings report on May 14 showed earnings per share of -31 cents, beating the estimate of -52 cents. With 1.56M shares outstanding, the current market capitalization sits at 360.47M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which engages in the research and development of a therapeutic treatment for mitochondrial disorders and Friedreich's ataxia
Industry Biotechnology
Profile
Details
Industry
N/A
Address
Three Bala Plaza East
Phone
+1 844 511-9056
Employees
71
Web
https://www.larimartx.com